Illinois Municipal Retirement Fund bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 18,492 shares of the company’s stock, valued at approximately $453,000.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Signaturefd LLC increased its holdings in Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares in the last quarter. Strs Ohio acquired a new position in shares of Astrana Health during the fourth quarter worth about $40,000. Tower Research Capital LLC TRC boosted its position in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares during the period. Finally, State of Wyoming purchased a new stake in shares of Astrana Health in the second quarter worth about $132,000. 52.77% of the stock is owned by hedge funds and other institutional investors.
Astrana Health Stock Down 1.7%
Shares of NASDAQ:ASTH opened at $40.31 on Friday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The company has a fifty day simple moving average of $41.78 and a 200 day simple moving average of $31.87. The firm has a market cap of $2.25 billion, a PE ratio of 66.08 and a beta of 0.89. Astrana Health, Inc. has a 12-month low of $18.08 and a 12-month high of $51.60.
Analyst Ratings Changes
ASTH has been the topic of several analyst reports. TD Cowen raised their target price on Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Truist Financial upped their price target on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Needham & Company LLC increased their price objective on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. BTIG Research raised their price target on shares of Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Robert W. Baird set a $45.00 price target on Astrana Health in a research note on Friday, May 8th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Astrana Health has a consensus rating of “Moderate Buy” and a consensus target price of $47.86.
Read Our Latest Research Report on ASTH
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
See Also
- Five stocks we like better than Astrana Health
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
